XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
136 hedge funds and large institutions have $863M invested in Acceleron Pharma in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 46 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
16% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 25
50% less call options, than puts
Call options by funds: $1.14M | Put options by funds: $2.29M
Holders
136
Holding in Top 10
4
Calls
$1.14M
Puts
$2.29M
Top Buyers
| 1 | +$95.2M | |
| 2 | +$15.9M | |
| 3 | +$13.9M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$9.53M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$8.31M |
Top Sellers
| 1 | -$23.2M | |
| 2 | -$18.6M | |
| 3 | -$13.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.6M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$9.45M |